Actively Recruiting
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
Led by Centre Hospitalier Universitaire de Besancon · Updated on 2024-12-27
220
Participants Needed
4
Research Sites
495 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to evaluate modulation of anti-tumor T cell responses in cancer patients treated by concomitant radiochemotherapy (i-RTCT)
CONDITIONS
Official Title
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed non-small cell lung cancer, small cell lung cancer, or head and neck cancer
- Candidate for first-line concomitant radiochemotherapy
- Able and willing to provide written informed consent
You will not qualify if you...
- Previous sequential radiochemotherapy, exclusive radiotherapy, or stereotactic radiotherapy
- History of adjuvant radiochemotherapy for cancer treatment
- Current treatment with immunotherapy, chemotherapy, or immunosuppressive drugs except prednisone or prednisolone at 10 mg/day or less
- Known infection with HIV, hepatitis B, or hepatitis C virus
- Presence of any medical or psychiatric condition that could interfere with study participation
- Under legal guardianship, curatorship, or judicial protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
CHU de Besançon
Besançon, France, 25000
Actively Recruiting
2
Centre Georges François LECLERC
Dijon, France, 21000
Actively Recruiting
3
Hôpital Nord Franche-Comté
Montbéliard, France
Actively Recruiting
4
Institut Jean Godinot
Reims, France
Actively Recruiting
Research Team
O
Olivier ADOTEVI, Pr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here